Modern research data suggest a therapeutic role for serotonergic psychedelics in
depression and other neuropsychiatric disorders, although psychotomimetic effects may limit …

Post-traumatic stress disorder (PTSD) is a mental health condition that can occur following
exposure to a traumatic experience. An estimated 12 million US adults are presently affected …

Introduction The classic psychedelic psilocybin, found in some mushroom species, has
received renewed interest in clinical research, showing potential mental health benefits in …

Psilocybin is the most researched classic psychedelic for Treatment-Resistant Depression
(TRD). While optimizing set and setting are considered essential for efficacy and safety …

Introduction There has been increasing interest in the role psilocybin may play in the
treatment of depressive disorders. Several clinical trials have shown psilocybin to have …

We aim to systematically review and meta-analyze the effectiveness and safety of
psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating …

Classic psychedelics, including lysergic acid diethylamide (LSD), psilocybin, mescaline, N,
N-dimethyltryptamine (DMT) and 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), are …

Importance Interest in administering psychedelic agents as mental health treatment is
growing rapidly. As drugmakers invest in developing psychedelic medicines for several …

Background Prior data indicate limited ethnoracial diversity in studies testing psychedelic-
assisted treatments. Regulatory approval for psychedelic treatments may be imminent given …

Background: There is growing evidence for the therapeutic effects of the psychedelic drug
psilocybin for major depression. However, due to the lack of safety data on combining …